News

NPR: Kentucky backs away from plan to fund opioid treatment research with settlement money

Fifty billion dollars is on its way to state and local governments over the coming years. The pool of funding comes from multiple legal settlements with pharmaceutical companies that profited from manufacturing or selling opioid painkillers. As that money continues to be dispersed, officials are trying to figure out how to spend it best to help communities devastated by the deadly opioid epidemic.

Smithsonian Magazine: A Lesser-Known Psychedelic Drug Shows Promise for PTSD Treatment

Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans

Healthline: Psychedelic Ibogaine May Help PTSD and Depression After Traumatic Brain Injury

Press Release: Veterans Exploring Treatment Solutions (VETS) Grant Recipients Participate in Groundbreaking Stanford Study on Ibogaine Treatment for PTSD and TBI

Stanford Medicine News Center: Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets

Potent psychedelic drug banishes PTSD, small study finds

Military veterans with cognitive and psychological problems saw drastic improvements after a dose of ibogaine.

Biospace: Clinical trial on Ambio Life Sciences' ibogaine treatment for Navy SEALs with traumatic brain injury published in Nature Medicine